Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
SCOLR Pharma, Inc. (SCLR)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | | |
|
Returns on Capital |
ROIC (excluding intangibles) | -457.1% | -379.9% | -711.7% | -715.0% | -390.9% | -385.5% | | |
ROIC (including intangibles) | -604.3% | -227.0% | -374.3% | -1017.8% | -439.3% | -201.3% | -427.6% | |
ROE | -330.6% | -173.1% | -86.8% | -92.9% | -72.1% | -70.3% | -67.1% | |
ROA | -215.6% | -140.2% | -73.5% | -82.5% | -67.4% | -56.1% | -58.4% | |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 105.0 | 67.4 | 41.8 | 138.5 | 112.7 | 76.5 | |
Days payables outstanding | 2.2 | 2.2 | -7.7 | 20.8 | 4.7 | | | |
Cash conversion cycle | -2.2 | 102.8 | 75.2 | 21.0 | 133.8 | 112.7 | 76.5 | |
|